Similarly, KMT2A-MLLT3 AML cells impair HSC niche function and induce commitment of MSCs to differentiate into osteoprogenitor cells but not mature osteoblasts, leading to reduced bone mineralisation in vivo [24]. This evidence concerns the gene KMT2A and acute myeloid leukemia.